Title: Clinical Research of Prophylactic Treatment of Migraine on Tianshu Capsule
Abstract: Objective: To investigate the efficacy and safety of Tianshu capsule in prophylactic treatment of migraine.Method: A multicenter stratified block randomized,double blind,positive drug parallel controlled clinical trials were conducted.600 cases of migraine patients were divided into three groups,the treatment group was treated with oral Tianshu capsule 4 pills,tid;the control group was treated with oral sibelium capsules 2 pills,bid;the other control group was treated with oral Yuanhu Zhitong capsule 4 pills,tid.The treatment time was 12 weeks.Headache frequency,duration,VAS score of headache severity,symptom and adverse events of patients were recorded in follow-up study respectively on the First day,fourth weeks,eighth weeks,Twelfth weekend.Result: After 12 weeks treatment,Tianshu capsule improved the efficacy on relieving headache and TCM syndromes(syndrome of blood stasis mingled with hyperactivity of liver Yang),reduced headache frequency compared with those before treatment The curative effect was equivalent with flunarizine hydrochloride capsules,better than Yuanhu Zhitong capsule control group.The incidence of adverse reactions was equivalent with Yuanhu Zhitong capsule control group,lower than flunarizine hydrochloride.Conclusion: Tianshu capsule is the effective and safety drug for treatment and prevention of migraine.
Publication Year: 2013
Publication Date: 2013-01-01
Language: en
Type: article
Access and Citation
AI Researcher Chatbot
Get quick answers to your questions about the article from our AI researcher chatbot